title: Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors: Individualizing Treatment With SGLT-2 Inhibitor Therapy in Type 2 Diabetes Mellitus.
abstract: The largely self-managed nature of type 2 diabetes mellitus (T2DM) underscores the importance of a collaborative decision-making process between patient and provider that best aligns the medication characteristics with the needs, interests, and abilities of the patient and with the treatment goals. The treatment regimen should be kept as simple as possible. This article applies these general principles to the use of sodium glucose cotransporter-2 inhibitor (SGLT-2) therapy, based on evidence from published studies and the clinical experience of the author.
authors.affiliation: Executive Director and Co-founder, Diabetes Nation, High Lakes Health Care, St. Charles Hospital, Bend, OR, USA.
authors.forename: Eden M
authors.initials: EM
authors.lastname: Miller
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D057285:Precision Medicine; D051297:Sodium-Glucose Transporter 2 / Q000627:therapeutic use*; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D014481:United States
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors